Linda F. Hogle is Professor of Medical Social Sciences in the School of Medicine & Public Health at the University of Wisconsin-Madison and Fellow at the Wisconsin Institutes for Discovery. Her research includes analyses of social, ethical, and legal issues in emerging cell-based and biomedical engineering technologies, as well as concepts of risk in innovative science as understood by governance bodies. She has served as an advisor to several international research consortia focusing on stem cell and regenerative medicine. Contributors include:Sean P. Palecek, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WIDavid Schaffer, University of California-Berkeley, Department of Chemical and Biomolecular Engineering, CAPeter W. Zandstra, University of Toronto, Institute of Biomaterials and Biomedical Engineering, ON, Canada David B. Resnik, National Institute of Environmental Health Sciences, NCTania Bubela, University of Alberta, Department of Public Health Sciences, AB, CanadaAmrita Mishra, University of Alberta, Department of Public Health Sciences, AB, CanadaDebra J. H. Mathews, The Johns Hopkins University, Berman Institute of Bioethics, MDKevin E. Noonan, McDonnell Boehnen Hulbert & Berghoff LLP, ILPilar N. Ossorio, University of Wisconsin-Madison Law School, WIJessica von Reyn, University of Wisconsin-Madison Law School, WINancy M. P. King, Wake Forest University School of Medicine, Department of Social Sciences and Health Policy, NCAmritava Das, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WI